← Back to Search

Behavioural Intervention

Halo Neuroscience Neurostimulator for Progressive Supranuclear Palsy

N/A
Waitlist Available
Led By Maria Luisa Gorno Tempini, MD PhD
Research Sponsored by University of California, San Francisco
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and three months post treatment
Awards & highlights

Study Summary

tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study

Eligible Conditions
  • Progressive Supranuclear Palsy
  • Corticobasal Degeneration Syndrome
  • Cortical Basal Ganglionic Degeneration
  • Nonfluent Aphasia
  • Frontotemporal Dementia

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and three months post treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and three months post treatment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in speech intelligibility
Secondary outcome measures
Medical Devices

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: tDCS +speech therapy followed by sham tDCS + speech therapyExperimental Treatment1 Intervention
Group II: sham tDCS +speech therapy followed by tDCS + speech therapyActive Control1 Intervention

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor
2,505 Previous Clinical Trials
15,237,555 Total Patients Enrolled
Halo NeuroscienceIndustry Sponsor
Maria Luisa Gorno Tempini, MD PhDPrincipal InvestigatorUniversity of California, San Francisco

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
AphasiologyJournal
Augmentation of Spelling Therapy with Transcranial Direct Current Stimulation in Primary Progressive Aphasia: Preliminary Results and Challenges
Tsapkini, Kyrana, Constantine Frangakis, Yessenia Gomez, Cameron Davis, and Argye E. Hillis. 2014. “Augmentation of Spelling Therapy with Transcranial Direct Current Stimulation in Primary Progressive Aphasia: Preliminary Results and Challenges”. Aphasiology. Informa UK Limited. doi:10.1080/02687038.2014.930410.
BrainJournal
Retraining Speech Production and Fluency in Non-fluent/agrammatic Primary Progressive Aphasia
Henry, Maya L, H Isabel Hubbard, Stephanie M Grasso, Maria Luisa Mandelli, Stephen M Wilson, Mithra T Sathishkumar, Julius Fridriksson, et al.. 2018. “Retraining Speech Production and Fluency in Non-fluent/agrammatic Primary Progressive Aphasia”. Brain. Oxford University Press (OUP). doi:10.1093/brain/awy101.
clinicaltrials.govStudy
tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study
2022. "tDCS and Speech Therapy for Motor Speech Disorders Caused by FTLD Syndromes: a Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04883229.
~0 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top